期刊文献+

输注供者抗原特异性调节性T淋巴细胞延长小鼠胰岛移植物的存活时间

Infusion of donor-specific regulatory T cells prolonged islet allograft survival in mice
原文传递
导出
摘要 目的 研究体外扩增获得的供者抗原特异性调节性T淋巴细胞(Treg细胞)对小鼠同种胰岛移植物存活时间的影响.方法 建立从Balb/c小鼠到C57小鼠的胰岛移植模型,通过观察移植后小鼠血糖情况来判断移植胰岛的存活时间.受鼠制成糖尿病模型后分为3组.对照组:不给予任何处理,只观察血糖变化;单纯胰岛移植组:移植胰岛,但不输注Treg细胞;实验组:术前1 d静脉给予1×106个供者特异性Treg细胞,然后行胰岛移植.结果胰岛移植后,对照组小鼠血糖持续高于16.7 mmol/L;单纯胰岛移植组小鼠血糖于术后1~2 d全部降至正常,到7~11 d时陆续开始升高,并维持在术前水平,存活时间为(8.50±1.6)d;实验组小鼠血糖于术后2 d内降至正常,之后维持在较低水平,至第21天开始有小鼠血糖升高超过16.7 mmol/L,存活时间为(26.2±3.9)d,明显长于单纯胰岛移植组(P<0.05).结论 输注供者抗原特异性Treg细胞可以明显延长移植胰岛的存活时间,在胰岛移植耐受中有积极的作用. Objective To investigate the effects of donor-specific regulatory T cells (Treg) transfusion on islet allograft survival. Methods Allogeneic fresh islets from Balb/c mice were transplanted to streptozotocin-induced diabetic C57 mice. The survival of islet allografts was observed. The experiment was divided into 3 groups: control group, nothing had been done to the recipients; simple islet transplantation group, the recipients received the islet transplantation only; experimental group, the recipients were given 1 ×106 Treg, then received islet transplantation. Results Blood glucose (BG) was above 16. 7 mmol/L after islet transplantation in control group; In simple islet transplantation group,BG level returned to normal level 1 to 2 days after transplantation, and hyperglycemia appeared 7 to 11 days after transplantation and maintained as the same as that before transplantation; In experimental group, BG level returned to normal level 2 days after transplantation and maintained at a low level,and at the 21st day after transplantation BG level was over 16. 7mmol/L in some recipients. Islet allograft survival in experimental group was significantly prolonged as compared with simple islet transplantation group. Conclusion Donor-specific Treg transfusion could prolong the islet allograft survival,and maybe have positive effect on tolerance induction of islet transplantation.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2011年第1期20-23,共4页 Chinese Journal of Organ Transplantation
关键词 小鼠 胰岛移植 调节性T淋巴细胞 糖尿病 Mice Islets of langerhans transplantatiom Regulatory T-lymphocytes~ Diabetesmellitus
  • 相关文献

参考文献11

  • 1Kang SM,Tang Q,Bluestone JA.CD4+ CD25+ regulatory T cells in transplantation:progress,challenges and prospects.Am J Transplant,2007,7(6):1457-1463.
  • 2Pu LY,Wang XH,Zhang F,et al.Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4 (+) CD25 (+)regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.Surgery,2007,142(1):67-73.
  • 3Golshayan D,Jiang S,Tsang J,et al.In vitro-expanded donor alloantigen-specific CD4 + CD25 + regulatory T cells promote experimental transplantation tolerance.Blood,2007,109 (2):827-835.
  • 4吴轲,徐逸,昌盛,吴丁安,陈忠华,张伟杰.转化生长因子-β1联合白细胞介素-2体外诱导非肥胖糖尿病小鼠调节性T细胞的产生[J].中华实验外科杂志,2008,25(1):45-47. 被引量:2
  • 5汤高枫,张伟杰,陈必成,张翔.不成熟树突状细胞体外诱导T细胞表达转录因子Foxp3[J].中华器官移植杂志,2007,28(6):339-342. 被引量:1
  • 6Louis S,Braudeau C,Giral M,et al.Contrasting CD25highCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance.Transplantation,2006,81 (3):398407.
  • 7Zelenika D,Adams E,Humm S,et al.The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance.Immunol Rev,2001,182:164-179.
  • 8Meloni F,Vitulo P,Bianco AM,et al.Regulatory CD4+ CD25+T cells in the peripheral blood of lung transplant recipients:correlation with transplant outcome.Transplantation,2004,77(5):762-766.
  • 9Alvarez CM,Paris SC,Arango L,et al.Kidney transplant patients with long-term graft survival have altered expression of molecules associated with T-cell activation.Transplantation,2004,78(10):1541-1547.
  • 10李冬妹,胡永秀.CD4^+CD25^+ Treg细胞与移植免疫耐受[J].微生物学免疫学进展,2007,35(2):39-43. 被引量:5

二级参考文献67

  • 1周军,汪建平,兰平,吴小剑,黄美近,宋新明.结肠抗原特异性T细胞克隆回输治疗大鼠溃疡性结肠炎的研究[J].中华实验外科杂志,2004,21(10):1206-1208. 被引量:14
  • 2张弘炜,史留斌,彭承宏.CD4^+CD25^+T细胞联合CD154单抗抑制大鼠肝移植急性排斥反应的研究[J].中华实验外科杂志,2007,24(2):196-198. 被引量:8
  • 3Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol,2005 ,23 :447-485.
  • 4Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nature Rev Immunol,2003 ,3 :253-257.
  • 5Chen W,Jin W,Hardegen N,et al. Conversion of peripheral CD4^+ CD25^ - Naive T cells to CD4^+ CD25^+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med,2003,198 : 1875- 1886.
  • 6Thornton AM, Donovan EE, Piccirillo CA, et al. Cutting edge: IL-2 is critically required for the in vitro activation of CD4^+ CD25^+ T cell suppressor function. J Immunol,2004,172:6519-6523.
  • 7Masteller EL,Warner MR,Tang Q,et al. Expansion of functional endogenous antigen-specific CD4^+ CD25^+ regulatory T cells from nonobese diabetic mice. J Immunol,2005 175:3053-3059.
  • 8Schwartz RH. Models of T cell anergy: is there a common molecular mechanism? J Exp Med, 1996,184 : 1-8.
  • 9Song GZ,Ju HW,William S,et al. TGF-β Requires CTIA-4 early after T Cell Activation to Induce Foxp3 and generate Adaptive CD4^+ CD25^ + regulatory cells1. J Immunol,2006 ,176 :3321-3329.
  • 10Jaeckel E, Boehmer H, Manns MP. Antigen-specific Foxp3-transduced T-cells can control established type 1 diabetes. Diabetes, 2005,54: 306-310.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部